Net revenues for Q1 2026 were $27.9 million, a 7% decrease compared to $29.9 million in Q1 2025. Net loss widened to $22.38 million from $16.04 million in the prior year period. Operating loss increased to $23.27 million, driven by higher R&D spending and lower revenues. Gross profit margin improved to 42.3% from 41.1% due to operational efficiencies and improved product mix. The company executed a workforce reduction in Q1 2026 to align its cost structure, incurring $1.27 million in termination benefits.